Vor Biopharma Inc.

NASDAQ:VOR

Biotechnology

Healthcare
$17.83 -2.26%

-$0.34 today

Market cap
$966.13M
Beta
1.73
P/E (TTM)
-0.0
EPS (TTM)
-$2,053.13
52W Low $4.28High $65.80

Volume 0.79M

Average 1.07M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$142.71M

FY 2025 · Annual

Investing Cash Flow

-$48.80M

FY 2025 · Annual

Financing Cash Flow

$503.81M

FY 2025 · Annual

+843.6% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(68.9M)(92.09M)(117.86M)(116.91M)(695.98M)
Depreciation & Amortization1.43M2.53M3.49M3.53M2.89M
Deferred Income Tax00000
Stock-Based Compensation4.32M10.7M13.36M9.85M18.91M
Change in Working Capital(9.19M)(12.69M)650K5K10.21M
Accounts Receivables00000
Inventory00000
Accounts Payables405K02.85M2.24M0
Other Working Capital(9.59M)(12.69M)(2.2M)(2.24M)10.21M
Other Non-Cash Items3.19M6.42M67K3.87M521.26M
Operating Cash Flow(69.14M)(85.14M)(100.29M)(99.66M)(142.71M)
Capital Expenditures(3.89M)(8.46M)(1.07M)(229K)(941K)
Acquisitions (Net)00000
Purchases of Investments(87.76M)(123.19M)(74.92M)(9.91M)(53.66M)
Sales of Investments037.56M147M107M5M
Other Investing Activities0000799K
Investing Cash Flow(91.65M)(94.09M)71.01M96.86M(48.8M)
Debt Repayment00000
Common Stock Issued189.2M115.98M4.58M55.83M505.13M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(1.66M)1.17M(1.64M)(2.43M)(1.33M)
Financing Cash Flow232.91M117.14M2.94M53.39M503.81M
Effect of Forex Changes00000
Net Change in Cash72.12M(62.1M)(26.35M)50.59M312.29M
Free Cash Flow(73.04M)(93.61M)(101.36M)(99.89M)(143.65M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$696.0M
+ D&A$2.9M
+ Stock-Based Comp$18.9M
+ Deferred Tax$0
+ Working Capital$10.2M
+ Other Non-Cash$521.3M
= Operating Cash Flow-$142.7M
- Capex-$941.0K
= Free Cash Flow-$143.7M

Analysis

FY2025 free cash flow is -$143.7M. FCF conversion is 20.6% of net income. Operating cash flow was -$142.7M, with capex of -$941.0K. The largest bridge item is Other Non-Cash at $521.3M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
4Statement of changes in beneficial ownershipNov 4, 2026
424B5424B5 filingOct 30, 2026
10-QQuarterly reportOct 30, 2026

Does VOR generate free cash flow?

Vor Biopharma Inc. (VOR) generated -$143.65M of free cash flow in fiscal 2025.

How much operating cash flow does VOR produce?

Operating cash flow was -$142.71M, before capital expenditures of $941,000.00.